Provider
Selective Serotonin Inverse Agonist (SSIA) - Medicaid
Program effective Date: Jul 01, 2024
Documents & Forms Results
Displaying 1351 - 1360 of 3110 results
Provider
Low Molecular Weight Heparins (LMWH) and Arixtra - Medicaid
Program effective Date: Jul 01, 2024
Provider
Lyrica® and Savella® - Medicaid
Program effective Date: Jul 01, 2024
Provider
Lyrica® (pregabalin) Savella® (milnaciprin)
Step Therapy, Quantity Limit
Program effective Date: Jul 01, 2024
Provider
Attention Deficit [Hyperactivity] Disorder (ADHD/ADD) Agents - Commercial
Program effective Date: Jul 01, 2024
Provider
Low Molecular Weight Heparins (LMWH) and Arixtra - Commercial
Quantity Limit
Program effective Date: Jul 01, 2024
Provider
QP96R1-23 EXL Health (EXL) to Perform Inpatient Facility Claim Reviews
Program effective Date: Jun 26, 2024
Provider
QP51-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 15, 2024
Program effective Date: Jun 26, 2024
Provider
QP50-24 Training Webinars for New Medical Drug Vendor, MagellanRx Management
Program effective Date: Jun 26, 2024
Provider
QP52-24 Appeal Submissions Now Available in Availity Essentials: Create, Submit and Inquire for Minnesota Health Care Programs Post-Service Claim Appeals
Program effective Date: Jun 26, 2024